|
WO2009048328A1
|
|
Differentiation between brca1-associated and sporadic tumours
|
|
EP1980626A1
|
|
Involvement of lipid kinase, and signal transduction pathway comprising said lipid kinase, in resistance to HER2-targeting therapy
|
|
WO2007049955A1
|
|
Prediction of local recurrence of breast cancer
|
|
GB0617379D0
|
|
Digital polling system and method
|
|
WO2008007942A1
|
|
Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof
|
|
GB0610778D0
|
|
Phosphatidylinositol phospahte and apoptosis
|
|
GB0508354D0
|
|
Phosphtidylinositol phosphate and apoptosis
|
|
EP1683808A1
|
|
Means and methods for breaking noncovalent binding interactions between molecules
|
|
EP1672365A1
|
|
Means and methods for determining and/or influencing cellular transportation
|
|
WO2005046637A2
|
|
Pharmaceutical formulations employing short-chain sphingolipids and their use
|
|
EP1627923A1
|
|
Means and methods for detecting and/or staging a follicular lymphoma cells
|
|
GB0326759D0
|
|
Pharmaceutical formulations and their preparation and use
|
|
GB0326642D0
|
|
Pharmaceutical formulations
|
|
EP1118661A1
|
|
T cell receptor libraries
|
|
CA2244812A1
|
|
Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
|
